波动性感音神经性听力损失的研究进展

朱倩晨; 张康佳; 邹曙光; 毛秋月; 汪芹; 邓建航; 伍伟景

doi:10.13201/j.issn.2096-7993.2023.03.017

波动性感音神经性听力损失的研究进展

- 中南大学湘雅二医院耳鼻咽喉头颈外科中南大学耳科研究所(长沙，410011)

详细信息

通讯作者: 伍伟景，E-mail：weijwu@163.com

中图分类号: R764.43

收稿日期: 2022-04-21

刊出日期: 2023-03-03

Advances in the study of fluctuating sensorineural hearing loss

- Department of Otolaryngology Head and Neck Surgery, the Second Xiangya Hospital, Central South University, Institute of Otolology, Central South University, Changsha, 410011, China

More Information

Corresponding author: WU Weijing, E-mail: weijwu@163.com

Received Date: 21 April 2022

Publish Date: 03 March 2023

摘要

摘要: 波动性感音神经性听力损失(FSNHL)是一种特殊类型的感音神经性听力损失，可在多种临床疾病中表现出来。本文综述了与FSNHL相关的一些临床疾病，如梅尼埃病、大前庭水管综合征、急性低频感音神经性听力损失、迟发性膜迷路积水、自身免疫性内耳病及导致FSNHL的综合征，总结FSNHL的发病机制、诊断及治疗，以期提高临床医师对FSNHL的认识，降低误诊率，改善患者预后。
- 波动性感音神经性听力损失 /
- 梅尼埃病 /
- 迟发性膜迷路积水 /
- 自身免疫性内耳病 /
- 综合征性耳聋
Abstract: Fluctuating sensorineural hearing loss(FSNHL) is a special type of sensorineural hearing loss, which can be manifested in many clinical diseases. In this paper, some clinical diseases associated with FSNHL are summarized, such as Meniere's disease, large vestibular aqueduct syndrome, acute low frequency sensorineural hearing loss, delayed endolymphatic hydrops, autoimmune inner ear disease and syndromes leading to FSNHL. The pathogenesis, diagnosis and treatment of FSNHL were summarized in order to improve clinicians' understanding of FSNHL, reduce the probability of misdiagnosis of related diseases and improve the prognosis of patients.
- fluctuating sensorineural hearing loss /
- Meniere's disease /
- delayed endolymphatic hydrops /
- autoimmune inner ear disease /
- syndromic deafness

HTML全文

参考文献(37)

[1]	Liu H, Zhou K, Zhang X, et al. Fluctuating Sensorineural Hearing Loss[J]. Audiol Neurootol, 2019, 24(3): 109-116. doi: 10.1159/000500658
[2]	刘洁, 蒋雯, 林欢, 等. 梅尼埃病患者宽频声导抗测试特点初步研究[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(12): 1068-1072. doi: 10.13201/j.issn.2096-7993.2021.12.003 http://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=722d11cd-d988-4ff5-b836-6169965a4c01
[3]	Zhang N, Lyu Y, Guo J, et al. Bidirectional Transport of IgE by CD23 in the Inner Ear of Patients with Meniere's Disease[J]. J Immunol, 2022, 208(4): 827-838. doi: 10.4049/jimmunol.2100745
[4]	Kitahara T, DoiK, Maekawa C, et al. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors[J]. J Neuroendocrinol, 2008, 20(12): 1295-1300. doi: 10.1111/j.1365-2826.2008.01792.x
[5]	Sajjadi H, Paparella MM. Meniere's disease[J]. Lancet, 2008, 372(9636): 406-414. doi: 10.1016/S0140-6736(08)61161-7
[6]	Nishio A, Ito T, Cheng H, et al. Slc26a4 expression prevents fluctuation of hearing in a mouse model of large vestibular aqueduct syndrome[J]. Neuroscience, 2016, 329: 74-82. doi: 10.1016/j.neuroscience.2016.04.042
[7]	Ito T, Nishio A, Wangemann P, et al. Progressive irreversible hearing loss is caused by stria vascularis degeneration in an Slc26a4-insufficient mouse model of large vestibular aqueduct syndrome[J]. Neuroscience, 2015, 310: 188-197. doi: 10.1016/j.neuroscience.2015.09.016
[8]	Kim JS, Son SE, Kim MB, et al. Significance of Pseudo-Conductive Hearing Loss and Positional Nystagmus for Perilymphatic Fistula: Are They Related to Third-Window Effects?[J]. Clin Exp Otorhinolaryngol, 2021, 14(3): 268-277. doi: 10.21053/ceo.2020.01942
[9]	刘佳星, 黄丽辉, 傅新星, 等. 大前庭水管综合征患儿听力学检测特点分析[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(21): 1702-1705, 1709. doi: 10.13201/j.issn.1001-1781.2016.21.009 http://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=aa45bb46-a359-443a-a75b-d964a4d570a8
[10]	Liu X, Ren L, Li J, et al. Air and bone-conducted vestibular evoked myogenic potentials in children with large vestibular aqueduct syndrome[J]. Acta Otolaryngol, 2021, 141(1): 50-56. doi: 10.1080/00016489.2020.1815836
[11]	Stölzel K, Droste J, Voß LJ, et al. Comorbid Symptoms Occurring During Acute Low-Tone Hearing Loss(AHLH)as Potential Predictors of Menière's Disease[J]. Front Neurol, 2018, 9: 884. doi: 10.3389/fneur.2018.00884
[12]	Fukuoka H, Tsukada K, Miyagawa M, et al. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent(GBCA)administration with MRI for Meniere's disease[J]. Acta Otolaryngol, 2010, 130(1): 10-16. doi: 10.3109/00016480902858881
[13]	Ma Y, Sun Q, Zhang K, et al. High level of IgE in acute low-tone sensorineural hearing loss: A predictor for recurrence and Meniere Disease transformation[J]. Am J Otolaryngol, 2021, 42(2): 102856. doi: 10.1016/j.amjoto.2020.102856
[14]	吴侃, 王大勇, 王浩然, 等. 以波动性低频感音神经性聋为特征的疾病诊断与转归分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(2): 106-112. doi: 10.13201/j.issn.1001-1781.2020.02.003 http://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=7697c61f-1c21-4117-9e3c-59babb8d0016
[15]	Inui H, Sakamoto T, Ito T, et al. Magnetic resonance imaging of the endolymphatic space in patients with acute low-tone sensorineural hearing loss[J]. Auris Nasus Larynx, 2019, 46(6): 859-865. doi: 10.1016/j.anl.2019.04.003
[16]	Leong JL, Chen CH, Huang CY, et al. Combination Therapy and Single-Modality Treatment for Acute Low-Tone Hearing Loss: A Meta-Analysis with Trial Sequential Analysis[J]. Brain Sci, 2022, 12(7): 866. doi: 10.3390/brainsci12070866
[17]	Suzuki M, Hanamitsu M, Kitanishi T, et al. Autoantibodies against inner ear proteins in patients with delayed endolymphatic hydrops and unilateral juvenile deafness[J]. Acta Otolaryngol, 2006, 126(2): 117-121. doi: 10.1080/00016480500266008
[18]	Chen BJ, Luo WW, Zhao WD, et al. The transcriptome characteristics of vestibular organs from delayed endolymphatic hydrops patients(Meniere's disease)[J]. Clin Otolaryngol, 2021, 46(4): 823-833. doi: 10.1111/coa.13748
[19]	陈耔辰, 张玉忠, 徐勇, 等. 迟发性膜迷路积水的研究现状[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(23): 1862-1866. doi: 10.13201/j.issn.1001-1781.2017.23.021 http://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=51adafd6-cd01-4c01-a671-35c78cc039ec
[20]	Liu B, Zhang S, Leng Y, et al. Intratympanic injection in delayed endolymphatic hydrops[J]. Acta Otolaryngol, 2015, 135(10): 1016-1021. doi: 10.3109/00016489.2015.1052984
[21]	Shojaku H, Takakura H, Asai M, et al. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops[J]. Acta Otolaryngol, 2021, 141(11): 977-983. doi: 10.1080/00016489.2021.1989485
[22]	Zhang D, Lv Y, Li X, et al. Long-term efficacy of triple semicircular canal plugging in the treatment of patients with ipsilateral delayed endolymphatic hydrops[J]. Sci Rep, 2021, 11(1): 3156. doi: 10.1038/s41598-021-82683-6
[23]	Miwa T, Okano T. Role of Inner Ear Macrophages and Autoimmune/Autoinflammatory Mechanisms in the Pathophysiology of Inner Ear Disease[J]. Front Neurol, 2022, 13: 861992. doi: 10.3389/fneur.2022.861992
[24]	Pathak S, Vambutas A. Autoimmune inner ear disease patient-associated 28-kDa proinflammatory IL-1β fragment results from caspase-7-mediated cleavage in vitro[J]. JCI Insight, 2020, 5(3): e130845. doi: 10.1172/jci.insight.130845
[25]	Mijovic T, Zeitouni A, Colmegna I. Autoimmune sensorineural hearing loss: the otology-rheumatology interface[J]. Rheumatology(Oxford), 2013, 52(5): 780-789. doi: 10.1093/rheumatology/ket009
[26]	Girasoli L, Cazzador D, Padoan R, et al. Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment[J]. J Immunol Res, 2018, 2018: 5072582.
[27]	李熙星, 陈雨濛, 张光远, 等. 免疫介导的感音神经性听力损失患病率及治疗策略[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(7): 663-667. doi: 10.13201/j.issn.2096-7993.2020.07.022 http://lceh.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=3fc6cc92-41b8-44cc-91b5-bdb8d2eb322b
[28]	Vázquez-Román V, Cameselle-Teijeiro JM, Fernández-Santos JM, et al. Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process[J]. Endocr Pathol, 2022, 33(4): 484-493. doi: 10.1007/s12022-022-09732-2
[29]	Baroncelli GI, Mora S. X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management[J]. Front Endocrinol(Lausanne), 2021, 12: 688309. doi: 10.3389/fendo.2021.688309
[30]	Pantel G, Probst R, Podvinec M, et al. Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia[J]. J Laryngol Otol, 2009, 123(1): 136-140. doi: 10.1017/S0022215107001636
[31]	Marrodan M, Correale J, Alessandro L, et al. Susac Syndrome: A differential diagnosis of white matter lesions[J]. Mult Scler Relat Disord, 2017, 15: 42-46. doi: 10.1016/j.msard.2017.04.007
[32]	Marrodan M, Fiol MP, Correale J. Susac syndrome: challenges in the diagnosis and treatment[J]. Brain, 2022, 145(3): 858-871. doi: 10.1093/brain/awab476
[33]	Dörr J, Krautwald S, Wildemann B, et al. Characteristics of Susac syndrome: a review of all reported cases[J]. Nat Rev Neurol, 2013, 9(6): 307-316. doi: 10.1038/nrneurol.2013.82
[34]	Rennebohm RM, Asdaghi N, Srivastava S, et al. Guidelines for treatment of Susac syndrome-An update[J]. Int J Stroke, 2020, 15(5): 484-494. doi: 10.1177/1747493017751737
[35]	Fowler KB. Congenital cytomegalovirus infection: audiologic outcome[J]. Clin Infect Dis, 2013, 57 Suppl 4(Suppl 4): S182-S184.
[36]	Chern A, Famuyide AO, Moonis G, et al. Bilateral Sudden Sensorineural Hearing Loss and Intralabyrinthine Hemorrhage in a Patient With COVID-19[J]. Otol Neurotol, 2021, 42(1): e10-e14. doi: 10.1097/MAO.0000000000002860
[37]	Rocha AJ, Márquez R, García-Berrocal JR. Cerebellar gangliocytoma as a cause of fluctuating hearing loss[J]. Clin Case Rep, 2020, 8(12): 2923-2925.